Linking soluble vascular adhesion molecule-1 level to calcific aortic stenosis in patients with coronary artery disease

Experimental and Clinical Cardiology

Volumn 14, Issue 3, 2009, Pages

  Linhartova, Katerina ^a,b   Sterbakova, Gabriela ^b   Racek, Jaroslav ^b   Cerbak, Roman ^c   Porazikova, Karolina ^a   Rokyta, Richard ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

Author keywords

Adhesion molecules; Aortic stenosis; Calcification; VCAM 1

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; VASCULAR ADHESION PROTEIN 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ATHEROSCLEROSIS; AORTA STENOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 74549143712     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic disease. J Am Coll Cardiol 1997;29:630-4.
2. Chan K. Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003;42:593-9.
3. Libby P. The vascular biology of atherosclerosis. In: Zipes DP, Libby P, Bonow RO, Braunwald E. Heart Disease, 8th edn. Philadelphia: Elsevier Saunders, 2007.
4. Ray KK, Morrow DA, Shui A, Rifai N, Cannon CP. Relation between soluble intercellular adhesve molecule-1, statin therapy, and long term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT -TIMI 22). Am J Cardiol 2006;98:861-5.
5. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82.
6. Ghaisas NK, Foley JB, O'Brian DS, Crean P, Kelleher D. Adhesion molecules in nonrheumatic aortic valve disease: Endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol 2000;36:2257-62.
7. Linhartova K, Veselka J, Sterbakova G, Racek J, Topolcan O, Cerbak R. Parathyroid hormone and Vitamin D levels are independently associated with calcific aortic stenosis. Circ J 2008;72:245-50.
8. Zoghbi WA, Enriquez-Sarano M, Foster E, et al; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
9. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end stage calcified aortic valve stenosis. J Am Coll Cardiol 2004;43:1670-6.
10. Kalluri R, Zeisberg E. Controlling angiogenesis in heart valves. Nat Med 2006;12:1118-9.
11. Soini Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol 2003;34:756-63.
12. Mohler ER III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
13. Shahi CN, Ghaisas NK, Goggins M, et al. Elevated levels of circulating soluble adhesion molecules in patients with nonrheumatic aortic stenosis. Am J Cardiol 1997;79:980-2.
14. Selcoki Y, Turgut F, Kanbay M, et al. Cardiac valve calcifications and predictive parameters in hemodialysis patients. CEJ Med 2007;2:304-12.
15. Jeevanantham V, Singh N, Izuora K, et al. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease. Mayo Clin Proc 2007;82:171-4.
16. Novaro GM, Katz R, Aviles RJ, et al. Clinical factors, but not C-reactive protein predict progression of calcific aortic valve disease. J Am Coll Cardiol 2007;50:1992-9.